Related Experiment Video

Updated: Mar 10, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

18.9K

Pediatric disorders of pigmentation commonly seen in skin of color

Mona Ascha1, Mahwish Irfan2

  • 1Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Seminars in Cutaneous Medicine and Surgery
|December 6, 2016
PubMed

Insights

Accurate diagnosis of hyperpigmentation and hypopigmentation disorders in children with skin of color is crucial for timely treatment. This review aids physicians in identifying common pediatric pigmentary conditions, improving patient outcomes.

Area of Science:

  • Pediatric Dermatology
  • Dermatology
  • Genetics

Background:

  • Pigmentary disorders, including hyperpigmentation and hypopigmentation, present unique challenges in children with skin of color.
  • Accurate and timely diagnosis is essential to prevent treatment delays and improve quality of life for affected children.
  • The varied etiologies and similar clinical presentations of pigmentary disorders necessitate specialized diagnostic skills.

Purpose of the Study:

  • To review common disorders of hyperpigmentation and hypopigmentation in pediatric patients with skin of color.
  • To equip physicians with knowledge for enhanced clinical detection of these pigmentary conditions.
  • To address the specific needs of a vulnerable pediatric population with skin of color.

Main Methods:

  • Literature review of common pediatric pigmentary disorders.
  • Analysis of clinical presentations and diagnostic criteria.
  • Focus on conditions prevalent in children with skin of color.

Main Results:

  • Identification of key hyperpigmentary and hypopigmentary disorders common in children with skin of color.
  • Discussion of differential diagnoses and diagnostic pearls.
  • Emphasis on the importance of early and accurate diagnosis for effective management.

Conclusions:

  • Physicians require specific knowledge to accurately diagnose pigmentary disorders in children with skin of color.
  • Enhanced clinical detection strategies can significantly improve patient care and outcomes.
  • This review serves as a valuable resource for clinicians managing pediatric pigmentary conditions.

Keywords:
disorders of pigmentationhyperpigmentationhypopigmentationpediatric pigment disorders

More Related Videos

Quantification of Hypopigmentation Activity In Vitro06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

12.1K
Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

952

Related Concept Videos

Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
4.8K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.0K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
6.0K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
411
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306